Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAISE: Eltrombopag in chronic ITP
NCT00370331Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Started Nov 2006; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00370331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370331.